Ad Code: 41485

Patients with established coronary heart disease (CHD) require targeted risk management strategies and treatments, including lipid lowering therapy (LLT), to help reduce their risks for subsequent cardiovascular (CV) events and...

Antihypertensive medication effectiveness for protecting against heart attack, stroke, and vascular death is not affected by whether the medication is taken in the morning or evening, according to a late-breaking study presented...

Extravascular implantable cardioverter-defibrillators (ICDs) can be safely implanted, according to a study published in the New England Journal of Medicine. Paul Friedman, MD, and colleagues conducted a prospective,...

New research was presented at ESC 2022, the annual European Society of Cardiology Congress, from August 26-29. The features below highlight some of the studies that emerged from the conference. ‘Polypill’ Reduces Secondary CV...